Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $411.65 | 14 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bausch & Lomb, a division of Bausch Health US, LLC | $135.11 | 2 | $0 (2019) |
| Shire North American Group Inc | $113.64 | 6 | $0 (2018) |
| Alcon Laboratories Inc | $92.57 | 2 | $0 (2018) |
| OPTOVUE, INC. | $28.16 | 1 | $0 (2018) |
| Allergan Inc. | $19.69 | 1 | $0 (2018) |
| Sun Pharmaceutical Industries Inc. | $12.50 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $74.71 | 1 | Bausch & Lomb, a division of Bausch Health US, LLC ($74.71) |
| 2018 | $178.55 | 7 | Bausch & Lomb, a division of Bausch Health US, LLC ($60.40) |
| 2017 | $158.39 | 6 | Alcon Laboratories Inc ($77.38) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/07/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $74.71 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/10/2018 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: OPTHALMICS | ||||||
| 05/08/2018 | Alcon Laboratories Inc | ReSTOR (Device) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Ophthalmology | ||||||
| 05/02/2018 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: OPTHALMICS | ||||||
| 03/08/2018 | Allergan Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: RETINA | ||||||
| 01/25/2018 | Bausch & Lomb, a division of Bausch Health US, LLC | LOTEMAX GEL (Drug) | Food and Beverage | In-kind items and services | $60.40 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/23/2018 | OPTOVUE, INC. | OCT (Device) | Food and Beverage | Cash or cash equivalent | $28.16 | General |
| Category: Optometrist | ||||||
| 01/03/2018 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: OPTHALMICS | ||||||
| 11/01/2017 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: OPTHALMICS | ||||||
| 09/25/2017 | TissueTech, Inc. | Prokera (Device), AmnioGraft, AmnioGuard | Food and Beverage | Cash or cash equivalent | $9.98 | General |
| Category: Medical Device (510K) | ||||||
| 09/06/2017 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: OPTHALMICS | ||||||
| 05/18/2017 | Alcon Laboratories Inc | AcrySof (Device), ORA | Food and Beverage | In-kind items and services | $77.38 | General |
| Category: Ophthalmology | ||||||
| 05/03/2017 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: OPTHALMICS | ||||||
| 04/14/2017 | Sun Pharmaceutical Industries Inc. | Bromsite (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 1 | 12 | 12 | $780.00 | $167.36 |
All Medicare Procedures & Services
1 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2020 | 12 | 12 | $780.00 | $167.36 | 21.5% |
About Dr. Michael Norris, OD
Dr. Michael Norris, OD is a Optometrist healthcare provider based in Wynne, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1023116258.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Norris, OD has received a total of $411.65 in payments from pharmaceutical and medical device companies, with $74.71 received in 2019. These payments were reported across 14 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($411.65).
As a Medicare-enrolled provider, Norris has provided services to 12 Medicare beneficiaries, totaling 12 services with total Medicare billing of $167.36. Data is available for 1 year (2020–2020), covering 1 distinct procedure/service records.
Practice Information
- Specialty Optometrist
- Location Wynne, AR
- Active Since 09/20/2006
- Last Updated 03/04/2008
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1023116258
Products in Payments
- XIIDRA (Drug) $113.64
- AcrySof (Device) $77.38
- VYZULTA (Drug) $74.71
- LOTEMAX GEL (Drug) $60.40
- OCT (Device) $28.16
- OZURDEX (Drug) $19.69
- ReSTOR (Device) $15.19
- Bromsite (Drug) $12.50
- Prokera (Device) $9.98
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.